Coris BioConcept is a pioneering company specializing in the development of rapid diagnostic kits, particularly for the detection of human infectious pathogens and antibiotic resistance markers. Established in 1996, the Belgium-based firm has garnered recognition for its expertise in immunochromatographic, isothermal LAMP, and electrochemical technologies, widely utilized in microbiology laboratories globally. The company actively participates in multiple collaborative international projects funded by Belgian and European grants, focusing on the creation of new rapid diagnostic assays, with a special emphasis on antimicrobial resistance and neglected tropical and emerging diseases.
Coris BioConcept's commitment to R&D excellence positions it ideally to cater to the cutting-edge biotechnological demands of a rapidly developing world. Their products, entirely compliant with CE marking necessities, and the company's ISO 13485 certification underscore their dedication to quality and adherence to international standards.
There is no investment information
No recent news or press coverage available for CORIS BIOCONCEPT.